Cargando…
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation
The metabolic syndrome (MetS) is an escalating problem worldwide, causing left ventricular stiffening, an early characteristic of diastolic dysfunction for which no treatment exists. As diastolic dysfunction and stiffening in MetS patients are associated with increased circulating dipeptidyl peptida...
Autores principales: | Cuijpers, Ilona, Papageorgiou, Anna‐Pia, Carai, Paolo, Herwig, Melissa, Mügge, Andreas, Klein, Thomas, Hamdani, Nazha, Jones, Elizabeth A. V., Heymans, Stephane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812306/ https://www.ncbi.nlm.nih.gov/pubmed/33295687 http://dx.doi.org/10.1111/jcmm.16122 |
Ejemplares similares
-
Human myocytes are protected from titin aggregation-induced stiffening by small heat shock proteins
por: Kötter, Sebastian, et al.
Publicado: (2014) -
Tampering with springs: phosphorylation of titin affecting the mechanical function of cardiomyocytes
por: Hamdani, Nazha, et al.
Publicado: (2017) -
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
por: Michel, Konstanze, et al.
Publicado: (2020) -
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D
por: Herwig, Melissa, et al.
Publicado: (2020) -
Sema3A promotes the resolution of cardiac inflammation after myocardial infarction
por: Rienks, Marieke, et al.
Publicado: (2017)